Skip to main content
Meera Hameed, MD, Pathology, New York, NY, Memorial Sloan Kettering Cancer Center

MeeraHameedMD

Pathology New York, NY

Blood Banking & Transfusion Medicine, Molecular Genetics, Anatomic Pathology, Clinical Pathology

Professor, Pathology & Laboratory Medicine, Weill Cornell Medical College

Dr. Hameed is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Hameed's full profile

Already have an account?

Education & Training

  • Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer CenterFellowship, Blood Banking/Transfusion Medicine, 1992 - 1994
  • Drexel University College of Medicine/Hahnemann University Hospital
    Drexel University College of Medicine/Hahnemann University HospitalResidency, Pathology-Anatomic and Clinical, 1988 - 1992
  • Kilpauk Medical College
    Kilpauk Medical CollegeClass of 1981

Certifications & Licensure

  • NY State Medical License
    NY State Medical License 1992 - 2025
  • NJ State Medical License
    NJ State Medical License 1995 - 2025
  • PA State Medical License
    PA State Medical License 1991 - 1992
  • American Board of Pathology Anatomic Pathology & Clinical Pathology
  • American Board of Pathology Molecular Genetic Pathology

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Diagnosis of Known Sarcoma Fusions and Novel Fusion Partners by Targeted RNA Sequencing with Identification of a Recurrent ACTB-FOSB Fusion in Pseudomyogenic Hemangioe...  
    Brian P Rubin, Meera R Hameed, Khedoudja Nafa, David S Klimstra, Nature
  • Discovery of a Periosteal Stem Cell Mediating Intramembranous Bone Formation  
    John H Healey, Mathias P Bostrom, Matthew B Greenblatt, Meera Hameed, Dan Avi Landau, Nature
  • The Role of a Monoclonal Antibody 11C8B1 as a Diagnostic Marker of IDH2-Mutated Sinonasal Undifferentiated Carcinoma  
    Snjezana Dogan, Meera Hameed, Ronald A Ghossein, Deborah J Chute, Nature
  • Join now to see all

Press Mentions

  • Nirogacestat May Improve Outcomes for People with Sarcoma
    Nirogacestat May Improve Outcomes for People with SarcomaMarch 12th, 2023
  • Nirogacestat Improves Outcomes for People with Sarcoma, Shows Phase 3 Clinical Trial
    Nirogacestat Improves Outcomes for People with Sarcoma, Shows Phase 3 Clinical TrialMarch 10th, 2023
  • Innovation Changes the Way MSK’s Pathology Team Cares for Patients During COVID-19 Pandemic
    Innovation Changes the Way MSK’s Pathology Team Cares for Patients During COVID-19 PandemicSeptember 21st, 2020
  • Join now to see all

Hospital Affiliations